Novartis
Price
Price
CHART BY
Historical dividends and forecast
Novartis has so far distributed $3.761 in 2024. The next dividend will be paid on 11.03.2025
CHART BY
Frequently asked questions
What is Novartis's market capitalization?
What is Novartis's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Novartis?
What are the analyst ratings and target price for Novartis's stock?
What is Novartis's revenue over the trailing twelve months?
What is the EBITDA for Novartis?
What is the free cash flow of Novartis?
How many employees does Novartis have, and what sector and industry does it belong to?
What is the free float of Novartis's shares?
Financials
- Market Cap
- $169.67B
- EPS (TTM)
- $7.637
- Free Float
- 1.75B
- P/E ratio (TTM)
- 11.35
- Revenue (TTM)
- $42.90B
- EBITDA (TTM)
- $18.02B
- Free Cashflow (TTM)
- $12.95B
Pricing
- 1D span
- $95.87$97.60
- 52W span
- $91.65$121.34
Analyst Ratings
The price target is $115.85 and the stock is covered by 28 analysts.
Buy
6
Hold
19
Sell
3
Information
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
- Employees
- 76,057
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- CH0012005267
- Primary Ticker
- NOVN